The Effects of Intragastric Administration of Nutrients on Executive Control in Healthy Subjects.

NCT02800538 | Completed

• 1 other identifier: S56123
• Study Type: interventional
• Target: 26
• Locations: 1 country
• Sites: 1

Brief Summary

The previous research by one of our members in the research team (H. Miller) suggests a possible influence of oral nutrients intake of certain fat or carbohydrates (glucose, fructose) on executive control. On the other hand, another previous study from our group (L. Van Oudenhove) suggests a subliminal influence of intragastric administration of fatty acids on subjective and neural responses to negative emotion induction. The purpose of this study therefore is to examine the effect of intragastric administration of certain fatty acids and carbohydrates on executive control in healthy volunteers. Therefore one group of healthy volunteers are invited to the study. The participants will be randomly administered one of the three fatty acid emulsions or placebo via a nasogastric tube in each of the visits. After the exposure period, participants will use a computer to perform there different tasks to measure executive control. During each study visit, regular measurements of emotion, physical sensations, as well as blood glucose will be assessed. Furthermore, an electrocardiogram will be continuously recorded for the calculation of vagal function.

Conditions

Healthy Volunteers

Outcome Measures

Primary Outcomes (3)

• trial making task

  Participants will be required to connect a set of 25 numbered dots in numerical order as fast as possible while still maintaining accuracy.

  60 min after intervention

• digital span task

  Participants will be presented with a series of single-digit numbers and required to remember them. After the series has been presented the participants will need to indicate the numbers presented.

  60 min after intervention

• memory task

  A list of 15 words that are matched for frequency, concreteness, and imagery will be presented to the participant via a computer monitor at the rate of one every 2 sec. Afterwards they will be given 60 sec to write down as many words as they are able to recall from the list. Accuracy and errors will be recorded.

  60 min after intervention

Study Arms (4)

Lauric acid

EXPERIMENTAL

the nutrient that can be widely found in daily food.

Dietary Supplement: intragastric infusion of nutrient

Palmitic acid

EXPERIMENTAL

the nutrient that can be widely found in daily food.

Dietary Supplement: intragastric infusion of nutrient

Capric acid

EXPERIMENTAL

the nutrient that can be widely found in daily food.

Dietary Supplement: intragastric infusion of nutrient

Saline

PLACEBO COMPARATOR

physiological salt water

Dietary Supplement: intragastric infusion of nutrient

Interventions

intragastric infusion of nutrient DIETARY_SUPPLEMENT

Intragastric infusion of nutrient that can be widely found in daily food or placebo.

Capric acid; Lauric acid; Palmitic acid; Saline

Eligibility Criteria

• Age: 17 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• N = 26 These numbers are based on a power calculation for a repeated measures ANOVA with one within-subject factor using Gpower software version 3.1.7 (http://www.psycho.uni-duesseldorf.de/abteilungen/aap/gpower3), indicating that these sample sizes are needed to achieve 90% power to detect a medium-sized effect (f = 0.25).
• Men \& women
• Age: \>17 years
• ≤ BMI ≤ 25
• Of good mental and physical health

You may not qualify if:

• Participants with one or more of self-reported points below will be excluded:
• History of, or current presence of:
• Psychiatric disorders (e.g., anxiety disorders, somatization disorder, eating disorders, depression, substance-related disorders alcohol abuse or dependence etc.)
• Abnormal eating behavior (including restraint and emotional eating)
• Abdominal/thoracic surgery
• Neurological, endocrine or digestive related disorders
• Head trauma with loss of consciousness
• Other serious medical conditions
• Use of any drugs, including cannabis, during the past 6 months
• Current presence of:
• Pregnancy
• Medication use that affects the function of the gastrointestinal tract and/or affects the nervous system, psychotropics or painkillers
• A recent accident or surgery that has not fully recovered
• Other
• Smoking

Sponsors & Collaborators

• Universitaire Ziekenhuizen KU Leuven: lead
• KU Leuven: collaborator

Study Sites (1)

University Hospitals Leuven, campus Gasthuisberg

Leuven, 3000, Belgium

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: BASIC SCIENCE
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 6, 2016
• First Posted: June 15, 2016
• Study Start: May 25, 2015
• Primary Completion: June 27, 2017
• Study Completion: June 27, 2017
• Last Updated: September 11, 2017

Record last verified: 2016-11

Locations

BE (1)